FUJIFILM Cellular Dynamics Opens iPSC Headquarters and Manufacturing Facility in Wisconsin

FUJIFILM Cellular Dynamics celebrated the opening of its new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin on May 19.

Quadrupling the manufacturing footprint

The new site is expected to quadruple the company’s iPSC-based research products and services manufacturing footprint. It will also expand capabilities across its research product portfolio, including the iPSC-derived iCell product lines used in drug discovery.

Ready for cell therapy manufacturing

The facility is designed to accommodate future contract manufacturing of cell therapy products, from investigational drug manufacturing to commercial production.

A crucial next step

Tomoyuki Hasegawa, President and CEO of FUJIFILM Cellular Dynamics, said:

“The opening of this facility is an exciting milestone for FUJIFILM Cellular Dynamics and represents a crucial next step for scaling the infrastructure needed to support the next generation of iPSC-based research and therapeutics in the U.S. By expanding our development and manufacturing capabilities, we can better support partners working to translate stem cell science into real clinical impact.”